SEC Form 3 · accession 0000903423-15-000376
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Hobart
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 5, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities beneficially ownedF1,F2 | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Matthew Hobart is a TPG Partner. TPG is affiliated with (i) TPG Eagle Holdings, L.P., which directly holds an aggregate of 11,289,668 Class B Common Units (the "Class B Units") of Evolent Health LLC and 11,289,668 shares of Class B Common Stock (the "Class B Shares") of Evolent Health, Inc. (the "Issuer"), and (ii) TPG Growth II BDH, L.P. (together with TPG Eagle Holdings, L.P., the "TPG Funds"), which directly holds an aggregate of 2,384,636 shares of Class A Common Stock of the Issuer.
- F2Mr. Hobart disclaims beneficial ownership of all of the securities that are or may be beneficially owned by the TPG Funds or any of their affiliates. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that Mr. Hobart is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities of the Issuer for purposes of Section 16 of the Exchange Act or otherwise.
Remarks
(3) Ronald Cami is signing on behalf of Mr. Hobart pursuant to the authorization and designation letter dated May 13, 2015, which is filed as an exhibit hereto.